ASP Isotopes Inc. Common ...

4.20
-0.53 (-11.21%)
At close: Mar 28, 2025, 3:59 PM
4.20
0.12%
After-hours: Mar 28, 2025, 06:39 PM EDT

Company Description

ASP Isotopes Inc., a pre-commercial stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes.

It develops Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28.

The company also Uranium-235, an isotope of uranium for carbon-free energy industry.

ASP Isotopes Inc. was incorporated in 2021 and is based in Boca Raton, Florida.

ASP Isotopes Inc. Common Stock
ASP Isotopes Inc. Common Stock logo
Country United States
IPO Date Nov 10, 2022
Industry Chemicals
Sector Basic Materials
Employees 76
CEO Paul Elliot Mann C.F.A.

Contact Details

Address:
433 Plaza Real
Boca Raton, Florida
United States
Website aspisotopes.com

Stock Details

Ticker Symbol ASPI
Exchange NASDAQ
Fiscal Year n/a
Reporting Currency USD
CIK Code 0001921865
CUSIP Number 00218A105
ISIN Number US00218A1051
Employer ID 87-2618235
SIC Code 2890

Key Executives

Name Position
Dr. Gerdus Kemp M.D., Ph.D. Medical Director & Chief Executive Officer of Pet Labs
Paul Elliot Mann C.F.A. President, Chief Executive Officer & Executive Chairman
Dr. Hendrik Strydom B. Sc, M. Sc, Ph.D. Chief Technology Officer & Director
Heather Kiessling Chief Financial Officer
Robert Ainscow Chief Operating Officer
Dr. Xandra van Heerden Ph.D. Head of Research & Development
Hendrik T. van Wyk Head of Engineering
William Eden M.B.E. Global Head of HR & Director UK Nuclear Operations

Latest SEC Filings

Date Type Title
Mar 27, 2025 8-K Current Report
Feb 26, 2025 8-K Current Report
Feb 18, 2025 SCHEDULE 13G/A [Amend] Filing
Feb 18, 2025 SCHEDULE 13G/A [Amend] Filing
Feb 14, 2025 SCHEDULE 13G Filing
Feb 14, 2025 5 Filing
Feb 14, 2025 5 Filing
Feb 12, 2025 SCHEDULE 13G/A [Amend] Filing
Feb 04, 2025 SCHEDULE 13G Filing
Jan 13, 2025 8-K Current Report